# Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes

> **NCT02373865** · PHASE4 · TERMINATED · sponsor: **GWT-TUD GmbH** · enrollment: 4 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Glimepiride
- **DRUG:** Sitagliptin-Placebo
- **DRUG:** Glimepiride-Placebo

## Key facts

- **NCT ID:** NCT02373865
- **Lead sponsor:** GWT-TUD GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Premature termination due to insufficient patient recruitement..
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02373865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02373865, "Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02373865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*